Costs of schizophrenia and other psychoses in urban Australia: findings from the Low Prevalence (Psychotic) Disorders Study

References

• Andrews G. Is schizophrenia worth the cost?. Schizophrenia. WPA Series in Evidence and Experience in Psychiatry, M Maj, N Sartorius. John Wiley, Chichester 1999; 2: 455–457
   Google Scholar
• Andrews G. Meeting the unmet need with disease management. Unmet need in psychiatry: problems, resources, responses, G Andrews, S Henderson. Cambridge University Press, Cambridge 2000; 11–36
   Google Scholar
• Williams A. Calculating the global burden of disease: time for a strategic reappraisal?. Health Economics 1999; 8: 1–8
   PubMed Web of Science ®Google Scholar
• Mooney G, Wiseman V. Burden of disease and priority setting. Health Economics 2000; 9: 369–372
   PubMed Web of Science ®Google Scholar
• Murray C JL, Lopez A D. Progress and directions in refining the global burden of disease approach: a response to Williams. Health Economics 2000; 9: 69–82
   PubMed Web of Science ®Google Scholar
• Williams A. Comments on the response by Murray and Lopez. Health Economics 2000; 9: 83–86
   PubMed Web of Science ®Google Scholar
• Rice D P. Cost of illness studies–fact or fiction. Lancet 1994; 344: 1519–1520
   PubMed Web of Science ®Google Scholar
• Mugford M, Cooper N J. The value of COI studies (17th May, 2000). Electronic responses to: Byford, S., Torgerson, D.J., Raftery, J., Economic note: cost of illness studies. British Medical Journal. 2000; 320: 1335, [Cited 30 July 2002.] Available from URL: http://www.bmj.com/cgi/eletters/320/7245/1335#EL1
   Google Scholar
• Andrews G, Hall W, Goldstein G, Lapsley H, Bartels R, Silove D. The economic costs of schizophrenia: implications for public policy. Archives of General Psychiatry 1985; 42: 537–543
   PubMed Web of Science ®Google Scholar
• Hall W, Goldstein G, Andrews G, Lapsley H, Bartels R, Silove D. Estimating the economic costs of schizophrenia. Schizophrenia Bulletin 1985; 11: 598–611
   PubMed Web of Science ®Google Scholar
• Andrews G. The cost of schizophrenia revisited. Schizophrenia Bulletin 1991; 17: 389–394
   PubMed Web of Science ®Google Scholar
• Rice D P, Miller L S. Health economics and cost implications of anxiety and other mental disorders in the United States. British Journal of Psychiatry 1998; 173(Suppl. 34)4–9
   PubMed Web of Science ®Google Scholar
• De Hert M, Thys E, Boydens J, et al. Health care expenditure on schizophrenia patients in Belgium. Schizophrenia Bulletin 1998; 24: 519–527
   PubMed Web of Science ®Google Scholar
• Rund B R, Ruud T. Costs of services for schizophrenic patients in Norway. Acta Psychiatrica Scandinavica 1999; 99: 120–125
   PubMed Web of Science ®Google Scholar
• Goeree R, O'Brien B J, Goering P, et al. The economic burden of schizophrenia in Canada. Canadian Journal of Psychiatry 1999; 44: 464–472
   PubMed Web of Science ®Google Scholar
• McCrone P, Menezes P R, Johnson S, et al. Service use and costs of people with dual diagnosis in South London. Acta Psychiatrica Scandinavica 2000; 101: 464–472
   PubMed Web of Science ®Google Scholar
• Weinstein M C, Siegel J E, Garber A M, et al. Productivity costs, time costs and health-related quality of life: a response to the Erasmus Group. Health Economics 1997; 6: 505–510
   PubMed Web of Science ®Google Scholar
• Goeree R, O'Brien B J, Blackhouse G, Agro K, Goering P. The valuation of productivity costs due to premature mortality: a comparison of the human-capital and friction-cost methods for schizophrenia. Canadian Journal of Psychiatry 1999; 44: 455–463
   PubMed Web of Science ®Google Scholar
• Jablensky A, McGrath J, Herrman H, et al. People living with psychotic illness: an Australian study 1997–98. National survey of mental health and wellbeing. Mental Health Branch, Australian Commonwealth Department of Health and Aged Care, Canberra 1999, Report 4
   Google Scholar
• Jablensky A, McGrath J, Herrman H, et al. Psychotic disorders in urban areas: an overview of the methods and findings of the study on low prevalence disorders. Australian and New Zealand Journal of Psychiatry 2000; 34: 221–236
   PubMed Web of Science ®Google Scholar
• World Health Organization. WHO. Psychiatric Disability Assessment Schedule (WHO/DAS). World Health Organization, Geneva 1988
   Google Scholar
• McGuffin P, Farmer A, Harvey I. A polydiagnostic application of operational criteria in studies of psychotic illness. Archives of General Psychiatry 1991; 48: 764–770, Development and reliability of the OPCRIT system
   PubMed Web of Science ®Google Scholar
• Wing J K, Babor T, Brugha T, et al. SCAN Schedules for clinical assessment in neuropsychiatry. Archives of General Psychiatry 1990; 47: 589–593
   PubMed Web of Science ®Google Scholar
• Carr V J, Johnston P J, Lewin T J, Rajkumar S, Carter G L, Issakidis C. Patterns of service use among persons with schizophrenia and other psychotic disorders. Psychiatric Services 2003; 54, (in press)
   PubMed Web of Science ®Google Scholar
• American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 4th edn. American Psychiatric Association, Washington, DC 1994
   Google Scholar
• Drummond M F, O'Brien B, Stoddart G L, Torrance G W. Methods for the economic evaluation of health care programmes, 2nd edn. Oxford University Press, Oxford 1997
   Google Scholar
• Carr V, Neil A, Halpin S, Holmes S. Costs of psychosis in urban Australia. National survey of Mental Health and Wellbeing. Commonwealth Department of Health and Aged Care, Canberra, bulletin 2, [Cited 23 August 2002.] Available from URL: http://www.health.gov.au/hsdd/mentalhe/resources/reports/costs.htm
   Google Scholar
• Davies L M, Drummond M F. The economic burden of schizophrenia. Psychiatric Bulletin 1990; 14: 522–525
   Google Scholar
• Mueser K T, Drake R E, Bond G R. Recent advances in psychiatric rehabilitation for patients with severe mental illness. Harvard Review of Psychiatry 1997; 5: 123–137
   PubMed Web of Science ®Google Scholar
• Crowther R E, Marshall M, Bond G R, Huxley P. Helping people with severe mental illness to obtain work. British Medical Journal 2001; 322: 204–208
   PubMed Web of Science ®Google Scholar
• Knapp M, Almond S, Percudani M. Costs of schizophrenia: a review. Schizophrenia. WPA series in evidence and experience in psychiatry. John Wiley, Chichester 1999; 2: 407–454
   Google Scholar
• Singh B S, McGorry P D. The Second National Mental Health Plan: an opportunity to take stock and move forward. Medical Journal of Australia 1998; 169: 435–437
   PubMed Web of Science ®Google Scholar
• Voruganti L, Heslegrave R, Awad A, Seeman M. Quality of life measurement in schizophrenia. reconciling the quest for subjectivity with the question of reliability. Psychological Medicine 1998; 28: 165–172
   PubMed Web of Science ®Google Scholar